Report cover image

Pancreatic and Biliary Stents Market Outlook 2026-2034: Market Share, and Growth Analysis By Product (Plastic Stents, Metal Stents), By Application (Benign Biliary Structures, Bili-Pancreatic Leakages, Pancreatic Cancer, Others), By End-User

Publisher OG Analysis
Published Nov 11, 2025
SKU # OGAN20568642

Description

The Pancreatic and Biliary Stents Market is valued at USD 353.99 million in 2025 and is projected to grow at a CAGR of 6.5% to reach USD 648.2 million by 2034.

Pancreatic and Biliary Stents Market

The Pancreatic & Biliary Stents Market addresses endoscopic, EUS-guided, and percutaneous drainage of malignant and benign obstructions in the common bile duct and pancreatic duct, spanning plastic stents (straight, pigtail) and self-expanding metal stents (SEMS) - uncovered, partially, and fully covered - as well as lumen-apposing metal stents (LAMS) for EUS-guided gallbladder drainage and pancreatic fluid collections. Value creation hinges on patency, migration resistance, controlled radial force, anti-reflux design, and deliverability through tortuous anatomy under fluoroscopic and ultrasound guidance. Oncology (cholangiocarcinoma, pancreatic, periampullary tumors) and post-operative strictures dominate indications, while chronic pancreatitis and benign biliary strictures sustain exchange-driven volumes. Trends include thinner, more trackable delivery systems for altered anatomy, hydrophilic/low-friction coatings, anti-biofilm surfaces, and stents tuned for ERCP vs EUS roles. Hospitals and advanced ASCs weigh upfront device cost against exchange frequency, anesthesia time, readmission risk, and quality-of-life endpoints; reimbursement pathways and day-care protocols influence site-of-care shift. Competitive dynamics pit global endoscopy majors and specialized innovators against regional value players, with stickiness driven by physician preference, proctorship programs, and accessory ecosystems (sphincterotomes, guidewires, dilation, cholangioscopy). As cancer care pathways emphasize faster biliary decompression and fewer re-interventions, procurement favors platforms with strong clinical evidence, predictable deployment, and comprehensive training and service.

Pancreatic and Biliary Stents Market Key Insights

Plastic vs. metal: economics, patency, and exchange strategyPlastic stents remain favored for short-term drainage and benign disease due to lower unit cost and easy removal, but occlusion from sludge/biofilm necessitates planned exchanges. SEMS deliver higher radial force and longer patency in malignant obstruction, with covering choices balancing tissue ingrowth prevention against migration and side-branch access.
Covered, partially covered, and anti-migration design trade-offsFully covered SEMS aid removability and reduce ingrowth; partially covered variants seek anchoring without overgrowth; uncovered offer maximal frictional hold but risk tissue embedding. Flared ends, anchoring fins, and braided nitinol geometries tailor fixation, while anti-reflux valves target duodenobiliary reflux that accelerates occlusion.
EUS-guided interventions expand the addressable marketLAMS and dedicated EUS stents enable gallbladder drainage when ERCP is inaccessible, and create cystogastrostomy tracts for pancreatic fluid collections. Wider lumens improve drainage and endoscopic access for necrosectomy, but require rigorous training, cautery-enhanced delivery control, and post-deployment surveillance protocols.
Benign strictures demand planned, protocolized therapyMultistent plastic strategies or removable fully covered SEMS are used to remodel benign biliary and pancreatic strictures (e.g., post-surgical, chronic pancreatitis). Success depends on exchange cadence, dilation technique, and minimizing pancreatic irritation; clear pathways reduce recurrence and anesthesia exposure.
Materials & coatings: pushing patency and visibilityNitinol frameworks provide elastic recovery and kink resistance; PTFE/silicone coverings reduce sludge adherence; radiopaque markers and echogenic tips aid placement under dual imaging. Emerging surface treatments target biofilm control without compromising flexibility, while controlled radial force profiles protect fragile ducts.
System-level kits and accessories create stickinessProcedural reliability rests on compatible guidewires, cannulation catheters, dilation balloons, and sphincterotomes. Vendors that bundle stents with “pathway kits,” pre-shaped tips, and torque-responsive delivery gain share by shortening cannulation time and standardizing success across operator skill levels.
Cholangioscopy and imaging guide difficult anatomyDirect visualization supports stone management, biopsy, and stricture characterization, informing stent choice and length. Integration with digital scopes and AI-assisted lesion assessment is growing, but requires robust sterilization, workflow alignment, and capital justification for high-mix centers.
Complication mitigation is a procurement criterionPancreatitis, cholangitis, perforation, and bleeding risks are mitigated through atraumatic tips, smooth transitions, and reliable recapture. Hospitals scrutinize migration rates, occlusion curves, and ease of revision; post-market surveillance and registries strengthen trust during value-analysis reviews.
Reimbursement and site-of-care shifts influence portfoliosDay-care ERCP and ASC expansion prioritize predictable deployment, low fluoroscopy times, and minimal re-interventions. DRG/OPPS dynamics drive preference for devices that extend exchange intervals and reduce readmissions, while standardized UDI and consignment models simplify inventory control.
Regulatory and quality systems shape vendor selectionMDR and FDA expectations around biocompatibility, shelf-life, and PMS place a premium on robust clinical files and change control. Consistent IFU clarity, MRI labeling, and traceability - plus proctoring and credentialing support - are decisive for formulary access and multi-hospital wins.

Pancreatic and Biliary Stents Market Reginal Analysis

North America

High ERCP/EUS adoption and ASC growth favor easy-to-deploy SEMS and LAMS with reliable anti-migration features. Value analysis teams prioritize clinical evidence for reduced exchanges and complications. Integrated vendor training, on-call proctorship, and strong post-market data are key to system-wide standardization.

Europe

Stringent MDR documentation and multidisciplinary tumor boards drive evidence-led selection. Preference leans toward covered/removable options for benign disease and long-patency SEMS for malignancy, with growing EUS use in centers of excellence. Hospitals value comprehensive accessory ecosystems, clear IFUs, and sustainability initiatives in reprocessing and packaging.

Asia-Pacific

Large patient volumes and expanding endoscopy infrastructure accelerate uptake of cost-effective plastic stents and selected SEMS, with rapid growth in EUS-guided therapies at tertiary centers. Training partnerships and local service footprints are critical; vendors win with broad size ranges, trackable delivery systems, and multilingual support.

Middle East & Africa

Referral centers expand ERCP programs, with gradual introduction of EUS-guided drainage in major hubs. Procurement emphasizes durable SEMS for malignant obstruction and dependable plastic options for benign cases. Reliable supply, physician training, and responsive technical support underpin vendor selection.

South & Central America

Public–private mixes and budget variability shape a two-tier market: plastic stents for accessibility and SEMS where long patency lowers total care cost. Skilled centers adopt EUS-guided LAMS for complex cases. Partners offering consignment, training, and streamlined logistics build durable relationships across hospital networks.

Pancreatic and Biliary Stents Market Segmentation

By Product
  • Plastic Stents
  • Metal Stents

    By Application
  • Benign Biliary Structures
  • Bili-Pancreatic Leakages
  • Pancreatic Cancer
  • Others

    By End-User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

    Key Market players

    Boston Scientific, Cook Medical, Olympus Corporation, Taewoong Medical, M.I.Tech (HANAROSTENT), Micro-Tech (Nanjing) Co., Ltd., W. L. Gore & Associates, Merit Medical Systems (Merit Endotek), CONMED Corporation, Medi-Globe Group (ENDO-FLEX), ELLA-CS, S&G Biotech (BONASTENT), Zeon Medical, Balton, Becton, Dickinson and Company (C. R. Bard)

    Pancreatic and Biliary Stents Market Analytics

    The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modelling, to assess supply–demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends.Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behaviour are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.

    Pancreatic and Biliary Stents Market Competitive Intelligence

    The competitive landscape is mapped through OG Analysis’ proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analyzed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption.Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across energy and industrial corridors.

    Countries Covered

    • North America — Pancreatic and Biliary Stents market data and outlook to 2034
      • United States
      • Canada
      • Mexico
    • Europe — Pancreatic and Biliary Stents market data and outlook to 2034
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • BeNeLux
      • Russia
      • Sweden
    • Asia-Pacific — Pancreatic and Biliary Stents market data and outlook to 2034
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Indonesia
      • Malaysia
      • Vietnam
    • Middle East and Africa — Pancreatic and Biliary Stents market data and outlook to 2034
      • Saudi Arabia
      • South Africa
      • Iran
      • UAE
      • Egypt
    • South and Central America — Pancreatic and Biliary Stents market data and outlook to 2034
      • Brazil
      • Argentina
      • Chile
      • Peru

    * We can include data and analysis of additional countries on demand.

    Research Methodology

    This study combines primary inputs from industry experts across the Pancreatic and Biliary Stents value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.

    Key Questions Addressed

  • What is the current and forecast market size of the Pancreatic and Biliary Stents industry at global, regional, and country levels?
  • Which types, applications, and technologies present the highest growth potential?
  • How are supply chains adapting to geopolitical and economic shocks?
  • What role do policy frameworks, trade flows, and sustainability targets play in shaping demand?
  • Who are the leading players, and how are their strategies evolving in the face of global uncertainty?
  • Which regional “hotspots” and customer segments will outpace the market, and what go-to-market and partnership models best support entry and expansion?
  • Where are the most investable opportunities—across technology roadmaps, sustainability-linked innovation, and M&A—and what is the best segment to invest over the next 3–5 years?

    Your Key Takeaways from the Pancreatic and Biliary Stents Market Report

    • Global Pancreatic and Biliary Stents market size and growth projections (CAGR), 2024-2034
    • Impact of Russia-Ukraine, Israel-Palestine, and Hamas conflicts on Pancreatic and Biliary Stents trade, costs, and supply chains
    • Pancreatic and Biliary Stents market size, share, and outlook across 5 regions and 27 countries, 2023-2034
    • Pancreatic and Biliary Stents market size, CAGR, and market share of key products, applications, and end-user verticals, 2023-2034
    • Short- and long-term Pancreatic and Biliary Stents market trends, drivers, restraints, and opportunities
    • Porter’s Five Forces analysis, technological developments, and Pancreatic and Biliary Stents supply chain analysis
    • Pancreatic and Biliary Stents trade analysis, Pancreatic and Biliary Stents market price analysis, and Pancreatic and Biliary Stents supply/demand dynamics
    • Profiles of 5 leading companies—overview, key strategies, financials, and products
    • Latest Pancreatic and Biliary Stents market news and developments

    • Table of Contents

    1. Table of Contents
    1.1 List of Tables
    1.2 List of Figures

    2. Global Pancreatic and Biliary Stents Market Summary, 2025
    2.1 Pancreatic and Biliary Stents Industry Overview
    2.1.1 Global Pancreatic and Biliary Stents Market Revenues (In US$ billion)
    2.2 Pancreatic and Biliary Stents Market Scope
    2.3 Research Methodology

    3. Pancreatic and Biliary Stents Market Insights, 2024-2034
    3.1 Pancreatic and Biliary Stents Market Drivers
    3.2 Pancreatic and Biliary Stents Market Restraints
    3.3 Pancreatic and Biliary Stents Market Opportunities
    3.4 Pancreatic and Biliary Stents Market Challenges
    3.5 Tariff Impact on Global Pancreatic and Biliary Stents Supply Chain Patterns

    4. Pancreatic and Biliary Stents Market Analytics
    4.1 Pancreatic and Biliary Stents Market Size and Share, Key Products, 2025 Vs 2034
    4.2 Pancreatic and Biliary Stents Market Size and Share, Dominant Applications, 2025 Vs 2034
    4.3 Pancreatic and Biliary Stents Market Size and Share, Leading End Uses, 2025 Vs 2034
    4.4 Pancreatic and Biliary Stents Market Size and Share, High Growth Countries, 2025 Vs 2034
    4.5 Five Forces Analysis for Global Pancreatic and Biliary Stents Market
    4.5.1 Pancreatic and Biliary Stents Industry Attractiveness Index, 2025
    4.5.2 Pancreatic and Biliary Stents Supplier Intelligence
    4.5.3 Pancreatic and Biliary Stents Buyer Intelligence
    4.5.4 Pancreatic and Biliary Stents Competition Intelligence
    4.5.5 Pancreatic and Biliary Stents Product Alternatives and Substitutes Intelligence
    4.5.6 Pancreatic and Biliary Stents Market Entry Intelligence

    5. Global Pancreatic and Biliary Stents Market Statistics – Industry Revenue, Market Share, Growth Trends and Forecast by segments, to 2034
    5.1 World Pancreatic and Biliary Stents Market Size, Potential and Growth Outlook, 2024- 2034 ($ billion)
    5.1 Global Pancreatic and Biliary Stents Sales Outlook and CAGR Growth By Product, 2024- 2034 ($ billion)
    5.2 Global Pancreatic and Biliary Stents Sales Outlook and CAGR Growth By Application, 2024- 2034 ($ billion)
    5.3 Global Pancreatic and Biliary Stents Sales Outlook and CAGR Growth By End-User, 2024- 2034 ($ billion)
    5.4 Global Pancreatic and Biliary Stents Market Sales Outlook and Growth by Region, 2024- 2034 ($ billion)

    6. Asia Pacific Pancreatic and Biliary Stents Industry Statistics – Market Size, Share, Competition and Outlook
    6.1 Asia Pacific Pancreatic and Biliary Stents Market Insights, 2025
    6.2 Asia Pacific Pancreatic and Biliary Stents Market Revenue Forecast By Product, 2024- 2034 (USD billion)
    6.3 Asia Pacific Pancreatic and Biliary Stents Market Revenue Forecast By Application, 2024- 2034 (USD billion)
    6.4 Asia Pacific Pancreatic and Biliary Stents Market Revenue Forecast By End-User, 2024- 2034 (USD billion)
    6.5 Asia Pacific Pancreatic and Biliary Stents Market Revenue Forecast by Country, 2024- 2034 (USD billion)
    6.5.1 China Pancreatic and Biliary Stents Market Size, Opportunities, Growth 2024- 2034
    6.5.2 India Pancreatic and Biliary Stents Market Size, Opportunities, Growth 2024- 2034
    6.5.3 Japan Pancreatic and Biliary Stents Market Size, Opportunities, Growth 2024- 2034
    6.5.4 Australia Pancreatic and Biliary Stents Market Size, Opportunities, Growth 2024- 2034

    7. Europe Pancreatic and Biliary Stents Market Data, Penetration, and Business Prospects to 2034
    7.1 Europe Pancreatic and Biliary Stents Market Key Findings, 2025
    7.2 Europe Pancreatic and Biliary Stents Market Size and Percentage Breakdown By Product, 2024- 2034 (USD billion)
    7.3 Europe Pancreatic and Biliary Stents Market Size and Percentage Breakdown By Application, 2024- 2034 (USD billion)
    7.4 Europe Pancreatic and Biliary Stents Market Size and Percentage Breakdown By End-User, 2024- 2034 (USD billion)
    7.5 Europe Pancreatic and Biliary Stents Market Size and Percentage Breakdown by Country, 2024- 2034 (USD billion)
    7.5.1 Germany Pancreatic and Biliary Stents Market Size, Trends, Growth Outlook to 2034
    7.5.2 United Kingdom Pancreatic and Biliary Stents Market Size, Trends, Growth Outlook to 2034
    7.5.2 France Pancreatic and Biliary Stents Market Size, Trends, Growth Outlook to 2034
    7.5.2 Italy Pancreatic and Biliary Stents Market Size, Trends, Growth Outlook to 2034
    7.5.2 Spain Pancreatic and Biliary Stents Market Size, Trends, Growth Outlook to 2034

    8. North America Pancreatic and Biliary Stents Market Size, Growth Trends, and Future Prospects to 2034
    8.1 North America Snapshot, 2025
    8.2 North America Pancreatic and Biliary Stents Market Analysis and Outlook By Product, 2024- 2034 ($ billion)
    8.3 North America Pancreatic and Biliary Stents Market Analysis and Outlook By Application, 2024- 2034 ($ billion)
    8.4 North America Pancreatic and Biliary Stents Market Analysis and Outlook By End-User, 2024- 2034 ($ billion)
    8.5 North America Pancreatic and Biliary Stents Market Analysis and Outlook by Country, 2024- 2034 ($ billion)
    8.5.1 United States Pancreatic and Biliary Stents Market Size, Share, Growth Trends and Forecast, 2024- 2034
    8.5.1 Canada Pancreatic and Biliary Stents Market Size, Share, Growth Trends and Forecast, 2024- 2034
    8.5.1 Mexico Pancreatic and Biliary Stents Market Size, Share, Growth Trends and Forecast, 2024- 2034

    9. South and Central America Pancreatic and Biliary Stents Market Drivers, Challenges, and Future Prospects
    9.1 Latin America Pancreatic and Biliary Stents Market Data, 2025
    9.2 Latin America Pancreatic and Biliary Stents Market Future By Product, 2024- 2034 ($ billion)
    9.3 Latin America Pancreatic and Biliary Stents Market Future By Application, 2024- 2034 ($ billion)
    9.4 Latin America Pancreatic and Biliary Stents Market Future By End-User, 2024- 2034 ($ billion)
    9.5 Latin America Pancreatic and Biliary Stents Market Future by Country, 2024- 2034 ($ billion)
    9.5.1 Brazil Pancreatic and Biliary Stents Market Size, Share and Opportunities to 2034
    9.5.2 Argentina Pancreatic and Biliary Stents Market Size, Share and Opportunities to 2034

    10. Middle East Africa Pancreatic and Biliary Stents Market Outlook and Growth Prospects
    10.1 Middle East Africa Overview, 2025
    10.2 Middle East Africa Pancreatic and Biliary Stents Market Statistics By Product, 2024- 2034 (USD billion)
    10.3 Middle East Africa Pancreatic and Biliary Stents Market Statistics By Application, 2024- 2034 (USD billion)
    10.4 Middle East Africa Pancreatic and Biliary Stents Market Statistics By End-User, 2024- 2034 (USD billion)
    10.5 Middle East Africa Pancreatic and Biliary Stents Market Statistics by Country, 2024- 2034 (USD billion)
    10.5.1 Middle East Pancreatic and Biliary Stents Market Value, Trends, Growth Forecasts to 2034
    10.5.2 Africa Pancreatic and Biliary Stents Market Value, Trends, Growth Forecasts to 2034

    11. Pancreatic and Biliary Stents Market Structure and Competitive Landscape
    11.1 Key Companies in Pancreatic and Biliary Stents Industry
    11.2 Pancreatic and Biliary Stents Business Overview
    11.3 Pancreatic and Biliary Stents Product Portfolio Analysis
    11.4 Financial Analysis
    11.5 SWOT Analysis

    12 Appendix
    12.1 Global Pancreatic and Biliary Stents Market Volume (Tons)
    12.1 Global Pancreatic and Biliary Stents Trade and Price Analysis
    12.2 Pancreatic and Biliary Stents Parent Market and Other Relevant Analysis
    12.3 Publisher Expertise
    12.2 Pancreatic and Biliary Stents Industry Report Sources and Methodology

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Request A Sample
    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us